Benzinga | Apr 28, 2021 07:08AM EDT

Teva Pharmaceutical Indus Q1 EPS $0.63 Beats $0.59 Estimate, Sales $4.00B Miss $4.02B Estimate

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 17.11 percent decrease over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $4.00 billion which missed the analyst consensus estimate of $4.02 billion by 0.50 percent. This is a 8.19 percent decrease over sales of $4.36 billion the same period last year.